Panion & BF Licenses Phosphate Binder To Torii
This article was originally published in PharmAsia News
Executive Summary
Taiwan's Panion & BF Biotech and Japan's Torii Pharmaceutical have agreed to a licensing deal for treating a major symptom of chronic kidney disease.